Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Fidia Spa ( (IT:FDA) ) is now available.
Fidia S.p.A. has converted six bonds from the seventh tranche of its convertible bond loan reserved for Global Growth Holding Limited into 12,000,000 new shares at a conversion price of €0.005 per share. The new shares are admitted to trading on the regulated market, increasing the company’s share capital by €60,000 to €11,467,761.90 and bringing the total number of shares outstanding to 135,078,639.
Following this transaction, the POC convertible bond loan has been subscribed for a nominal total of €1,750,000, while the related capital increase has reached €1,620,000, with 13 bonds from the seventh tranche subscribed but not yet converted. The ongoing conversions underscore Fidia’s continued use of equity‑linked financing to support its capital structure and potentially broaden its shareholder base through GGHL’s increasing stake.
More about Fidia Spa
Fidia S.p.A., headquartered in Turin and listed on Euronext Milan, is a global leader in numerical control technology and high‑performance integrated milling systems. The company focuses on applications for complex shapes, serving primarily the automotive mold sector and the aerospace industry with numerical controls, high‑speed milling machines and CAM software.
Average Trading Volume: 3,495,054
Technical Sentiment Signal: Strong Sell
Current Market Cap: €773.4K
For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.